NGM Bio Holdings, Inc.
Biotechnology · South San Francisco, CA, United States
- CompanyNGM Bio Holdings, Inc.South San Francisco, CA, United States
- Phone line+1 (650) 243-5555General business
NGM Bio Holdings, Inc. is a privately held biotechnology company based in South San Francisco, CA that filed a Form D exempt offering notice with the SEC on 27-MAR-2026.
Capabilities
Pharmaceutical manufacturing
Evidence for each capability
- Pharmaceutical manufacturing. Form D industry group: Biotechnology — SEC Form D data sets (private offerings)
People 4
Everyone else on file (1)
Diana Peng BockusExecutive Officer, Director
Source timeline
Record created from SEC Form D data sets (private offerings)
SEC Form D data sets (private offerings) ↗Diana Peng Bockus — Executive Officer, Director
SEC Form D data sets (private offerings) ↗Peter M. Svennilson — Director
SEC Form D data sets (private offerings) ↗Roger M. Perlmutter — Director
SEC Form D data sets (private offerings) ↗Tim Peng Kutzkey — Director
SEC Form D data sets (private offerings) ↗
Similar makers
enGene Therapeutics Inc.Biological Products, (No Diagnostic Substances) · Saint-Laurent1 shared capabilityChemomab Therapeutics Ltd.Pharmaceutical Preparations · Tel Aviv1 shared capabilityEntera Bio Ltd.Biological Products, (No Diagnostic Substances) · Jerusalem1 shared capabilityPluri Inc.Biological Products, (No Diagnostic Substances) · Haifa1 shared capabilityMereo BioPharma Group plcPharmaceutical Preparations · London1 shared capabilityInMed Pharmaceuticals Inc.Pharmaceutical Preparations · Vancouver1 shared capabilityDBV Technologies S.A.Biological Products, (No Diagnostic Substances) · Chatillon1 shared capabilityTarget Group Inc.Medicinal Chemicals & Botanical Products · Hamilton1 shared capability